Published on: 2026-07-22
Source: Government of the Russian Federation –
An important disclaimer is at the bottom of this article.
Deputy Prime Minister Tatyana Golikova held a meeting of the project committee on the national project “Long and Active Life.” The agenda included the results of the implementation of the national project and the federal projects within its framework for the first six months of 2026. Representatives from the Ministry of Health, Ministry of Industry and Trade, Ministry of Education and Science, the Presidential Administration, FMBA, FAS, Rosstat, and others participated in the meeting.
As noted by Tatyana Golikova, the level of achievement of the national project indicators at the end of the second quarter of 2026 was 98.3%. All targets have been met, and funds have been fully distributed to all participants.
The national project “Long and Active Life” implements a total of 11 federal projects, including projects aimed at combating cardiovascular and oncological diseases, diabetes, hepatitis C, improving emergency medical care, as well as training medical personnel.
As of the second quarter of the current year, within the framework of the national project, more than 1.7 million working citizens with risk factors for the development of chronic diseases have been covered by dispensary observation, which is 2.4 times the annual plan. Over 930,000 citizens were examined at their workplace, which is twice the annual plan. Preventive measures help prevent the development of disease and timely prescribe necessary treatment, contributing to the preservation of citizens’ health.
Within the framework of the federal project “Fight against cardiovascular diseases,” more than 1.1 million people at high risk of cardiovascular complications have been provided with free medications. This figure exceeds the annual target by 30%, and the expansion of recipient categories for medications contributes to the prevention of acute conditions.
During the implementation of the federal project “Combating oncological diseases,” treatment has been provided in more than 1.56 million cases in round-the-clock and day hospital settings, including the use of antitumor drug therapy, surgical, and radiation treatment methods.
Under the federal project “Fight Against Diabetes,” more than 63,000 children aged 2 to 17 with type 1 diabetes and almost 56,000 pregnant women suffering from diabetes have been provided free of charge with continuous glucose monitoring systems. About 687,000 people have been trained in schools for patients with diabetes.
As part of the federal project “Combating Hepatitis C,” treatment with direct-acting antiviral drugs has been prescribed to nearly 35,000 patients with chronic viral hepatitis C, both on an outpatient basis and in day hospital settings. This approach ensures high treatment efficacy. For example, more than 26,600 people have achieved a sustained virological response after therapy.
Over the six months of the current year, air medical services have evacuated more than 10,000 patients in emergency and urgent cases, which is 7.7% higher than the figure for the same period in 2025. This is critically important for providing timely assistance to citizens living in or located in remote and hard-to-reach areas.
In order to improve the accessibility of medical care, employment has been provided for over 4,600 second-year residents as trainee doctors, which accounts for 45% of the annual plan. In addition, more than 5,900 doctors have been assigned, including on a rotational basis, to medical organizations in the regions.
National research centers have conducted more than 160,000 consultations and consilia using telemedicine technologies.
This year, the approach to granting the status of a national medical research center has changed. The new list of 39 medical organizations awarded the status of national medical research center was approved on July 1, 2026.
Please note; This information is raw content obtained directly from the information source. It represents an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.